Medications
Editorial: Lurbinectedin for neuroendocrine tumors
A new editorial paper was published in Oncoscience, titled "Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer."
Oct 6, 2023
0
47
News tagged with free
Oncology & Cancer
Blood-based biomarker may redefine future treatment for advanced melanoma
Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma. A new study that assessed ctDNA in the blood of patients with BRAF wild-type (BRAF WT) stage III and IV ...
Oct 4, 2023
0
23
Diabetes
Metabolic signature can help predict which smokers will develop type 2 diabetes
New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD) in Hamburg (2–6 Oct) finds that cigarette smoking increases the risk of developing type 2 diabetes ...
Oct 3, 2023
0
2
Oncology & Cancer
Liquid biopsy may help identify which patients with non-small cell lung cancer will benefit most from radiation
A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, ...
Oct 2, 2023
0
19
Oncology & Cancer
Larger lymph node threshold found to optimize nasopharyngeal carcinoma outcomes
According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma ...
Sep 29, 2023
0
1
Medications
Combination immunotherapy shows no additional benefit for most advanced cancers, finds meta-analysis
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
59
Medications
Dabrafenib, trametinib found more effective in pediatric glioma with BRAF V600
Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a study ...
Sep 21, 2023
0
16
Oncology & Cancer
Real-time live tissue sensitivity assay for pancreatic adenocarcinoma
A new research paper titled "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma" has been published in Oncotarget.
Sep 19, 2023
0
12
Health
Q&A: Is gluten-free the way to be? A dive into the science
In the past decade, products bearing "gluten-free" labels have taken grocery store shelves by storm. But for generations of people who learned about food groups from visuals of pyramids with "breads and cereals" as their ...
Sep 14, 2023
0
6
Medications
FLAURA2 results demonstrate osimertinib plus chemotherapy superior compared to osimertinib alone
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented at the International Association ...
Sep 11, 2023
0
7
